Minister of State for Chemicals and Fertilizers Mansukh Mandaviya said on Tuesday that the government has devised a strategy along with the manufacturing companies to increase the domestic production and further import Amphotericin-B which aids in curing Mucormycosis, more popular as the black fungus infection, which is generally a complication post infection with Covid-19 throughout the world.
Mandaviya commented about the same after reviewing the requirement and supply status of the antifungal drug Amphotericin-B on Tuesday.
The Union Minister revealed the information in a series of posts on Twitter, In of the tweets, he said, “Reviewed requirement and supply position of Amphotericin-B which cures Mucormycosis. We have chalked out a strategy with manufacturers to ramp up domestic production as well as to import the drug from all over the world.”
In another tweet, Mandaviya further added, “We have already improved the supply of Amphotericin-B by many folds. But currently, we are facing a sudden demand surge. Let me assure you that we are committed to moving heaven and earth to make it available to needy patients.”
He also mentioned that the government has developed a system for efficient supply and distribution of Amphotericin-B. Mandaviya further assured that the shortage of the drug will be resolved as soon as possible and added, “We have also outlined the system for efficient distribution and supply chain management of Amphotericin-B. The shortage will get resolved at the earliest. I also urge states to use this drug judiciously by strictly following the guidelines.”
- Melukote – Vairamudi Festival – 2022
- Bengaluru metro to function on weekdays, closed on weekends from July 1
- India provides reciprocal exemption of EU Digital COVID Certificate to include Covishield, Covaxin
- PM Modi will address the Digital India beneficiaries at 11 am tomorrow
- Pvt hospitals will obtain Covid vaccine doses via CoWIN starting from July 1
Niti Aayog presents the list of names private sector banks for privatization
India’s first indigenous home-based self-testing Covid-19 kit launched commercially
DCGI waiver will bring foreign Covid-19 vaccines of Pfizer, Moderna one step closer